BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schirbel A, Reichert A, Roll S, Baumgart DC, Büning C, Wittig B, Wiedenmann B, Dignass A, Sturm A. Impact of pain on health-related quality of life in patients with inflammatory bowel disease. World J Gastroenterol 2010; 16(25): 3168-3177 [PMID: 20593502 DOI: 10.3748/wjg.v16.i25.3168] [Cited by in CrossRef: 76] [Cited by in F6Publishing: 65] [Article Influence: 6.9] [Reference Citation Analysis]
Number Citing Articles
1 D'Ugo S, Romano F, Sibio S, Bagaglini G, Sensi B, Biancone L, Monteleone G, Sica GS. Impact of surgery on quality of life in Crohn's disease: short- and mid-term follow-up. Updates Surg 2020;72:773-80. [PMID: 32185677 DOI: 10.1007/s13304-020-00738-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
2 Sweeney L, Moss-Morris R, Czuber-Dochan W, Murrells T, Norton C. Developing a better biopsychosocial understanding of pain in inflammatory bowel disease: a cross-sectional study. Eur J Gastroenterol Hepatol 2020;32:335-44. [PMID: 31851083 DOI: 10.1097/MEG.0000000000001615] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
3 Lucarini E, Parisio C, Branca JJV, Segnani C, Ippolito C, Pellegrini C, Antonioli L, Fornai M, Micheli L, Pacini A, Bernardini N, Blandizzi C, Ghelardini C, Di Cesare Mannelli L. Deepening the Mechanisms of Visceral Pain Persistence: An Evaluation of the Gut-Spinal Cord Relationship. Cells 2020;9:E1772. [PMID: 32722246 DOI: 10.3390/cells9081772] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
4 Dillman JR, Carlos RC, Smith EA, Davenport MS, De Matos Maillard V, Adler J. Relationship of Bowel MR Imaging to Health-related Quality of Life Measures in Newly Diagnosed Pediatric Small Bowel Crohn Disease. Radiology 2016;280:568-75. [PMID: 26840653 DOI: 10.1148/radiol.2016151727] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
5 Bao CH, Liu P, Liu HR, Wu LY, Jin XM, Wang SY, Shi Y, Zhang JY, Zeng XQ, Ma LL, Qin W, Zhao JM, Calhoun VD, Tian J, Wu HG. Differences in regional homogeneity between patients with Crohn's disease with and without abdominal pain revealed by resting-state functional magnetic resonance imaging. Pain 2016;157:1037-44. [PMID: 26761381 DOI: 10.1097/j.pain.0000000000000479] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
6 Roggenbuck D, Reinhold D, Schierack P, Bogdanos DP, Conrad K, Laass MW. Crohn's disease specific pancreatic antibodies: clinical and pathophysiological challenges. Clin Chem Lab Med. 2014;52:483-494. [PMID: 24231127 DOI: 10.1515/cclm-2013-0801] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.2] [Reference Citation Analysis]
7 Lönnfors S, Vermeire S, Greco M, Hommes D, Bell C, Avedano L. IBD and health-related quality of life -- discovering the true impact. J Crohns Colitis. 2014;8:1281-1286. [PMID: 24662394 DOI: 10.1016/j.crohns.2014.03.005] [Cited by in Crossref: 140] [Cited by in F6Publishing: 117] [Article Influence: 20.0] [Reference Citation Analysis]
8 Halpin SJ, Ford AC. Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: systematic review and meta-analysis. Am J Gastroenterol. 2012;107:1474-1482. [PMID: 22929759 DOI: 10.1038/ajg.2012.260] [Cited by in Crossref: 318] [Cited by in F6Publishing: 270] [Article Influence: 35.3] [Reference Citation Analysis]
9 Picard E, Carvalho FA, Agosti F, Bourinet E, Ardid D, Eschalier A, Daulhac L, Mallet C. Inhibition of Cav 3.2 calcium channels: A new target for colonic hypersensitivity associated with low-grade inflammation. Br J Pharmacol 2019;176:950-63. [PMID: 30714145 DOI: 10.1111/bph.14608] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
10 Wojtowicz AA, Greenley RN, Gumidyala AP, Rosen A, Williams SE. Pain severity and pain catastrophizing predict functional disability in youth with inflammatory bowel disease. J Crohns Colitis 2014;8:1118-24. [PMID: 24630487 DOI: 10.1016/j.crohns.2014.02.011] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
11 Zielińska A, Sałaga M, Włodarczyk M, Fichna J. Focus on current and future management possibilities in inflammatory bowel disease-related chronic pain. Int J Colorectal Dis 2019;34:217-27. [PMID: 30564910 DOI: 10.1007/s00384-018-3218-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 6.3] [Reference Citation Analysis]
12 Crocker JA, Yu H, Conaway M, Tuskey AG, Behm BW. Narcotic use and misuse in Crohn's disease. Inflamm Bowel Dis. 2014;20:2234-2238. [PMID: 25208105 DOI: 10.1097/mib.0000000000000194] [Cited by in Crossref: 25] [Cited by in F6Publishing: 11] [Article Influence: 4.2] [Reference Citation Analysis]
13 Rubio A, Pellissier S, Van Oudenhove L, Ly HG, Dupont P, Tack J, Dantzer C, Delon-martin C, Bonaz B. Brain responses to uncertainty about upcoming rectal discomfort in quiescent Crohn's disease - a fMRI study. Neurogastroenterol Motil 2016;28:1419-32. [DOI: 10.1111/nmo.12844] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
14 Lamb CA, Kennedy NA, Raine T, Hendy PA, Smith PJ, Limdi JK, Hayee B, Lomer MCE, Parkes GC, Selinger C, Barrett KJ, Davies RJ, Bennett C, Gittens S, Dunlop MG, Faiz O, Fraser A, Garrick V, Johnston PD, Parkes M, Sanderson J, Terry H;  IBD guidelines eDelphi consensus group; Gaya DR, Iqbal TH, Taylor SA, Smith M, Brookes M, Hansen R, Hawthorne AB. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut. 2019;68:s1-s106. [PMID: 31562236 DOI: 10.1136/gutjnl-2019-318484] [Cited by in Crossref: 361] [Cited by in F6Publishing: 255] [Article Influence: 180.5] [Reference Citation Analysis]
15 Cook KF, Schalet BD, Kallen MA, Rutsohn JP, Cella D. Establishing a common metric for self-reported pain: linking BPI Pain Interference and SF-36 Bodily Pain Subscale scores to the PROMIS Pain Interference metric. Qual Life Res 2015;24:2305-18. [PMID: 25894063 DOI: 10.1007/s11136-015-0987-6] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 5.3] [Reference Citation Analysis]
16 Benson S, Kattoor J, Wegner A, Hammes F, Reidick D, Grigoleit JS, Engler H, Oberbeck R, Schedlowski M, Elsenbruch S. Acute experimental endotoxemia induces visceral hypersensitivity and altered pain evaluation in healthy humans. Pain 2012;153:794-9. [PMID: 22264996 DOI: 10.1016/j.pain.2011.12.001] [Cited by in Crossref: 61] [Cited by in F6Publishing: 55] [Article Influence: 6.8] [Reference Citation Analysis]
17 Weaver E, Szigethy E. Managing Pain and Psychosocial Care in IBD: a Primer for the Practicing Gastroenterologist. Curr Gastroenterol Rep 2020;22:20. [PMID: 32185521 DOI: 10.1007/s11894-020-0757-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
18 Esteve R, Ramírez-maestre C. Pain Fear Avoidance and Pain Acceptance: A Cross-Sectional Study Comparing Their Influence on Adjustment to Chronic Pain Across Three Samples of Patients. ann behav med 2013;46:169-80. [DOI: 10.1007/s12160-013-9499-1] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
19 Zeitz J, Ak M, Müller-Mottet S, Scharl S, Biedermann L, Fournier N, Frei P, Pittet V, Scharl M, Fried M. Pain in IBD Patients: Very Frequent and Frequently Insufficiently Taken into Account. PLoS One. 2016;11:e0156666. [PMID: 27332879 DOI: 10.1371/journal.pone.0156666] [Cited by in Crossref: 51] [Cited by in F6Publishing: 39] [Article Influence: 10.2] [Reference Citation Analysis]
20 Farrell K, Rank M, Keely S, Brichta A, Graham B, Callister R. In vivo characterization of colorectal and cutaneous inputs to lumbosacral dorsal horn neurons in the mouse spinal cord. Neuroscience 2016;316:13-25. [DOI: 10.1016/j.neuroscience.2015.12.023] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
21 Falling C, Stebbings S, Baxter GD, Gearry RB, Mani R. Profile of musculoskeletal pain in patients with inflammatory bowel disease: a study protocol for assessing the multidimensional experience of self-reported pain. Physical Therapy Reviews 2018;23:227-35. [DOI: 10.1080/10833196.2018.1500149] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
22 Bonaz B, Sinniger V, Hoffmann D, Clarençon D, Mathieu N, Dantzer C, Vercueil L, Picq C, Trocmé C, Faure P, Cracowski JL, Pellissier S. Chronic vagus nerve stimulation in Crohn's disease: a 6-month follow-up pilot study. Neurogastroenterol Motil 2016;28:948-53. [PMID: 26920654 DOI: 10.1111/nmo.12792] [Cited by in Crossref: 250] [Cited by in F6Publishing: 202] [Article Influence: 50.0] [Reference Citation Analysis]
23 Gibson PR, Vaizey C, Black CM, Nicholls R, Weston AR, Bampton P, Sparrow M, Lawrance IC, Selby WS, Andrews JM, Walsh AJ, Hetzel DJ, Macrae FA, Moore GT, Weltman MD, Leong RW, Fan T. Relationship between disease severity and quality of life and assessment of health care utilization and cost for ulcerative colitis in Australia: a cross-sectional, observational study. J Crohns Colitis. 2014;8:598-606. [PMID: 24345767 DOI: 10.1016/j.crohns.2013.11.017] [Cited by in Crossref: 63] [Cited by in F6Publishing: 59] [Article Influence: 7.9] [Reference Citation Analysis]
24 Kleindienst N, Priebe K, Borgmann E, Cornelisse S, Krüger A, Ebner-Priemer U, Dyer A. Body self-evaluation and physical scars in patients with borderline personality disorder: an observational study. Borderline Personal Disord Emot Dysregul 2014;1:2. [PMID: 26401287 DOI: 10.1186/2051-6673-1-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
25 Ueno F, Nakayama Y, Hagiwara E, Kurimoto S, Hibi T. Impact of inflammatory bowel disease on Japanese patients' quality of life: results of a patient questionnaire survey. J Gastroenterol 2017;52:555-67. [PMID: 27470433 DOI: 10.1007/s00535-016-1241-x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 3.8] [Reference Citation Analysis]
26 Wright EK, Kamm MA. Impact of Drug Therapy and Surgery on Quality of Life in Crohnʼs Disease: A Systematic Review. Inflammatory Bowel Diseases 2015;21:1187-94. [DOI: 10.1097/mib.0000000000000271] [Cited by in Crossref: 45] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
27 Jain P, Hassan AM, Koyani CN, Mayerhofer R, Reichmann F, Farzi A, Schuligoi R, Malle E, Holzer P. Behavioral and molecular processing of visceral pain in the brain of mice: impact of colitis and psychological stress. Front Behav Neurosci. 2015;9:177. [PMID: 26217204 DOI: 10.3389/fnbeh.2015.00177] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
28 Srinath AI, Walter C, Newara MC, Szigethy EM. Pain management in patients with inflammatory bowel disease: insights for the clinician. Therap Adv Gastroenterol 2012;5:339-57. [PMID: 22973418 DOI: 10.1177/1756283X12446158] [Cited by in Crossref: 62] [Cited by in F6Publishing: 30] [Article Influence: 6.9] [Reference Citation Analysis]
29 van der Have M, van der Aalst KS, Kaptein AA, Leenders M, Siersema PD, Oldenburg B, Fidder HH. Determinants of health-related quality of life in Crohn's disease: a systematic review and meta-analysis. J Crohns Colitis. 2014;8:93-106. [PMID: 23746864 DOI: 10.1016/j.crohns.2013.04.007] [Cited by in Crossref: 71] [Cited by in F6Publishing: 49] [Article Influence: 8.9] [Reference Citation Analysis]
30 Rogler G, Singh A, Kavanaugh A, Rubin DT. Extraintestinal Manifestations of Inflammatory Bowel Disease: Current Concepts, Treatment, and Implications for Disease Management. Gastroenterology 2021:S0016-5085(21)03337-0. [PMID: 34358489 DOI: 10.1053/j.gastro.2021.07.042] [Reference Citation Analysis]
31 Ledergerber M, Lang BM, Heinrich H, Biedermann L, Begré S, Zeitz J, Krupka N, Rickenbacher A, Turina M, Greuter T, Schreiner P, Roth R, Siebenhüner A, Vavricka SR, Rogler G, Beerenwinkel N, Misselwitz B; Swiss IBD Cohort Study Group. Abdominal pain in patients with inflammatory bowel disease: association with single-nucleotide polymorphisms prevalent in irritable bowel syndrome and clinical management. BMC Gastroenterol 2021;21:53. [PMID: 33546600 DOI: 10.1186/s12876-021-01622-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
32 Wright EK, Kamm MA, De Cruz P, Hamilton AL, Ritchie KJ, Krejany EO, Gorelik A, Liew D, Prideaux L, Lawrance IC, Andrews JM, Bampton PA, Sparrow MP, Florin TH, Gibson PR, Debinski H, Gearry RB, Macrae FA, Leong RW, Kronborg I, Radford-smith G, Selby W, Johnston MJ, Woods R, Elliott PR, Bell SJ, Brown SJ, Connell WR, Desmond PV. Effect of Intestinal Resection on Quality of Life in Crohn's Disease. Journal of Crohn's and Colitis 2015;9:452-62. [DOI: 10.1093/ecco-jcc/jjv058] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
33 Jelsness-Jørgensen LP, Bernklev T, Moum B. Coexisting irritable bowel-like symptoms in inflammatory bowel disease in remission is associated with impaired social functioning and increased bodily pain. Gastroenterol Nurs. 2014;37:280-287. [PMID: 25078042 DOI: 10.1097/SGA.0000000000000055] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Hashash JG, Chintamaneni P, Ramos Rivers CM, Koutroubakis IE, Regueiro MD, Baidoo L, Swoger JM, Barrie A, Schwartz M, Dunn MA, Binion DG. Patterns of Antibiotic Exposure and Clinical Disease Activity in Inflammatory Bowel Disease: A 4-year Prospective Study. Inflamm Bowel Dis 2015;21:2576-82. [PMID: 26296061 DOI: 10.1097/MIB.0000000000000534] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
35 Chong KP, Woo BK. Emerging wearable technology applications in gastroenterology: A review of the literature. World J Gastroenterol 2021;27:1149-60. [PMID: 33828391 DOI: 10.3748/wjg.v27.i12.1149] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Morrison G, Van Langenberg DR, Gibson SJ, Gibson PR. Chronic pain in inflammatory bowel disease: characteristics and associations of a hospital-based cohort. Inflamm Bowel Dis. 2013;19:1210-1217. [PMID: 23524595 DOI: 10.1097/mib.0b013e318280e729] [Cited by in Crossref: 37] [Cited by in F6Publishing: 18] [Article Influence: 4.6] [Reference Citation Analysis]
37 Coates MD, Johri A, Gorrepati VS, Maheshwari P, Dalessio S, Walter V, Stuart A, Koltun W, Bernasko N, Tinsley A, Williams ED, Clarke K. Abdominal pain in quiescent inflammatory bowel disease. Int J Colorectal Dis 2021;36:93-102. [PMID: 32879990 DOI: 10.1007/s00384-020-03727-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Feagan BG, Hanauer SB, Coteur G, Schreiber S. Evaluation of a daily practice composite score for the assessment of Crohn’s disease: the treatment impact of certolizumab pegol: Composite score for certolizumab pegol response in Crohn’s disease. Alimentary Pharmacology & Therapeutics 2011;33:1143-51. [DOI: 10.1111/j.1365-2036.2011.04636.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
39 Laass MW, Roggenbuck D, Conrad K. Diagnosis and classification of Crohn’s disease. Autoimmun Rev. 2014;13:467-471. [PMID: 24424189 DOI: 10.1016/j.autrev.2014.01.029] [Cited by in Crossref: 106] [Cited by in F6Publishing: 82] [Article Influence: 15.1] [Reference Citation Analysis]
40 Farrell KE, Keely S, A. Graham B, Callister R, Callister RJ. A Systematic Review of the Evidence for Central Nervous System Plasticity in Animal Models of Inflammatory-mediated Gastrointestinal Pain: . Inflammatory Bowel Diseases 2014;20:176-95. [DOI: 10.1097/01.mib.0000437499.52922.b1] [Cited by in Crossref: 29] [Cited by in F6Publishing: 6] [Article Influence: 4.1] [Reference Citation Analysis]
41 Fu H, Kaminga AC, Peng Y, Feng T, Wang T, Wu X, Yang T. Associations between disease activity, social support and health-related quality of life in patients with inflammatory bowel diseases: the mediating role of psychological symptoms. BMC Gastroenterol 2020;20:11. [PMID: 31937264 DOI: 10.1186/s12876-020-1166-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
42 Na Y, Zhou J, Xiao XM, Zhang WX, Gao HL, Wang Y, Han XY, Sun ZC, Xu HM. Assessment of Crohn's disease activity by Doppler sonography. Saudi Med J 2017;38:391-5. [PMID: 28397945 DOI: 10.15537/smj.2017.4.17855] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
43 Rubio A, Van Oudenhove L, Pellissier S, Ly HG, Dupont P, Lafaye de Micheaux H, Tack J, Dantzer C, Delon-Martin C, Bonaz B. Uncertainty in anticipation of uncomfortable rectal distension is modulated by the autonomic nervous system--a fMRI study in healthy volunteers. Neuroimage 2015;107:10-22. [PMID: 25479021 DOI: 10.1016/j.neuroimage.2014.11.043] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 4.4] [Reference Citation Analysis]
44 Norton C, Czuber-Dochan W, Artom M, Sweeney L, Hart A. Systematic review: interventions for abdominal pain management in inflammatory bowel disease. Aliment Pharmacol Ther. 2017;46:115-125. [PMID: 28470846 DOI: 10.1111/apt.14108] [Cited by in Crossref: 38] [Cited by in F6Publishing: 29] [Article Influence: 9.5] [Reference Citation Analysis]
45 Regueiro M, Greer JB, Szigethy E. Etiology and Treatment of Pain and Psychosocial Issues in Patients with Inflammatory Bowel Diseases. Gastroenterology. 2017;152:430-439.e4. [PMID: 27816599 DOI: 10.1053/j.gastro.2016.10.036] [Cited by in Crossref: 50] [Cited by in F6Publishing: 44] [Article Influence: 10.0] [Reference Citation Analysis]
46 Sinniger V, Pellissier S, Fauvelle F, Trocmé C, Hoffmann D, Vercueil L, Cracowski J, David O, Bonaz B. A 12‐month pilot study outcomes of vagus nerve stimulation in Crohn's disease. Neurogastroenterology & Motility 2020;32. [DOI: 10.1111/nmo.13911] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 14.0] [Reference Citation Analysis]
47 Song G, Fiocchi C, Achkar JP. Acupuncture in Inflammatory Bowel Disease. Inflamm Bowel Dis 2019;25:1129-39. [PMID: 30535303 DOI: 10.1093/ibd/izy371] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 13.0] [Reference Citation Analysis]
48 Katz L, Tripp DA, Ropeleski M, Depew W, Curtis Nickel J, Vanner S, Beyak MJ. Mechanisms of Quality of Life and Social Support in Inflammatory Bowel Disease. J Clin Psychol Med Settings 2016;23:88-98. [DOI: 10.1007/s10880-015-9431-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
49 Schoultz M, Atherton IM, Hubbard G, Watson AJ. The use of mindfulness-based cognitive therapy for improving quality of life for inflammatory bowel disease patients: study protocol for a pilot randomised controlled trial with embedded process evaluation. Trials 2013;14:431. [PMID: 24341333 DOI: 10.1186/1745-6215-14-431] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
50 Conley S, Proctor DD, Jeon S, Sandler RS, Redeker NS. Symptom clusters in adults with inflammatory bowel disease. Res Nurs Health 2017;40:424-34. [PMID: 28833284 DOI: 10.1002/nur.21813] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 5.5] [Reference Citation Analysis]
51 Odes S, Friger M, Sergienko R, Schwartz D, Sarid O, Slonim-Nevo V, Singer T, Chernin E, Vardi H, Greenberg D, Israel Ibd Research Nucleus. Simple pain measures reveal psycho-social pathology in patients with Crohn's disease. World J Gastroenterol 2017;23:1076-89. [PMID: 28246482 DOI: 10.3748/wjg.v23.i6.1076] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
52 Ghosh S, Bressler B, Petkau J, Thakkar RB, Wang S, Skup M, Chao J, Panaccione R, Schreiber S. Healthcare Providers Underestimate Patients’ Glucocorticoid Use in Crohn’s Disease. Dig Dis Sci 2019;64:1142-9. [DOI: 10.1007/s10620-018-5419-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
53 Gater A, Kitchen H, Heron L, Pollard C, Håkan-Bloch J, Højbjerre L, Hansen BB, Strandberg-Larsen M. Development of a conceptual model evaluating the humanistic and economic burden of Crohn's disease: implications for patient-reported outcomes measurement and economic evaluation. Expert Rev Pharmacoecon Outcomes Res 2015;15:643-56. [PMID: 25985850 DOI: 10.1586/14737167.2015.1045883] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
54 Viola A, Monterubbianesi R, Scalisi G, Furfaro F, Rea M, Saibeni S, Aratari A, Bringiotti R, Casella G, Cantoro L, Frankovic I, Calella F, Pugliese D, Orlando S, Samperi L, Cappello M, Mocci G, Manetti N, Annese V, Privitera AC, Inserra G, Caprioli F, D’incà R, Principi M, Papi C, Castiglione F, Danese S, Ardizzone S, Bossa F, Kohn A, Manguso F, Alibrandi A, Fiorino G, Armuzzi A, Fries W. Late-onset Crohn’s disease: a comparison of disease behaviour and therapy with younger adult patients: the Italian Group for the Study of Inflammatory Bowel Disease ‘AGED’ study. European Journal of Gastroenterology & Hepatology 2019;31:1361-9. [DOI: 10.1097/meg.0000000000001546] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
55 Iskandar HN, Cassell B, Kanuri N, Gyawali CP, Gutierrez A, Dassopoulos T, Ciorba MA, Sayuk GS. Tricyclic antidepressants for management of residual symptoms in inflammatory bowel disease. J Clin Gastroenterol 2014;48:423-9. [PMID: 24406434 DOI: 10.1097/MCG.0000000000000049] [Cited by in Crossref: 40] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
56 Jain P, Materazzi S, De Logu F, Rossi Degl'Innocenti D, Fusi C, Li Puma S, Marone IM, Coppi E, Holzer P, Geppetti P, Nassini R. Transient receptor potential ankyrin 1 contributes to somatic pain hypersensitivity in experimental colitis. Sci Rep 2020;10:8632. [PMID: 32451393 DOI: 10.1038/s41598-020-65618-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
57 Brierley SM, Linden DR. Neuroplasticity and dysfunction after gastrointestinal inflammation. Nat Rev Gastroenterol Hepatol 2014;11:611-27. [PMID: 25001973 DOI: 10.1038/nrgastro.2014.103] [Cited by in Crossref: 140] [Cited by in F6Publishing: 124] [Article Influence: 20.0] [Reference Citation Analysis]
58 Cook KF, Dunn W, Griffith JW, Morrison MT, Tanquary J, Sabata D, Victorson D, Carey LM, Macdermid JC, Dudgeon BJ, Gershon RC. Pain assessment using the NIH Toolbox. Neurology 2013;80:S49-53. [PMID: 23479545 DOI: 10.1212/WNL.0b013e3182872e80] [Cited by in Crossref: 62] [Cited by in F6Publishing: 28] [Article Influence: 7.8] [Reference Citation Analysis]
59 Parisio C, Lucarini E, Micheli L, Toti A, Di Cesare Mannelli L, Antonini G, Panizzi E, Maidecchi A, Giovagnoni E, Lucci J, Ghelardini C. Researching New Therapeutic Approaches for Abdominal Visceral Pain Treatment: Preclinical Effects of an Assembled System of Molecules of Vegetal Origin. Nutrients 2019;12:E22. [PMID: 31861862 DOI: 10.3390/nu12010022] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
60 Knowles SR, Graff LA, Wilding H, Hewitt C, Keefer L, Mikocka-Walus A. Quality of Life in Inflammatory Bowel Disease: A Systematic Review and Meta-analyses-Part I. Inflamm Bowel Dis 2018;24:742-51. [PMID: 29562277 DOI: 10.1093/ibd/izx100] [Cited by in Crossref: 82] [Cited by in F6Publishing: 60] [Article Influence: 41.0] [Reference Citation Analysis]
61 Roda G, Chien Ng S, Kotze PG, Argollo M, Panaccione R, Spinelli A, Kaser A, Peyrin-Biroulet L, Danese S. Crohn's disease.Nat Rev Dis Primers. 2020;6:22. [PMID: 32242028 DOI: 10.1038/s41572-020-0156-2] [Cited by in Crossref: 47] [Cited by in F6Publishing: 29] [Article Influence: 47.0] [Reference Citation Analysis]
62 Farrell KE, Callister RJ, Keely S. Understanding and targeting centrally mediated visceral pain in inflammatory bowel disease. Front Pharmacol 2014;5:27. [PMID: 24634658 DOI: 10.3389/fphar.2014.00027] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.9] [Reference Citation Analysis]
63 Coates MD, Seth N, Clarke K, Abdul-Baki H, Mahoney N, Walter V, Regueiro MD, Ramos-Rivers C, Koutroubakis IE, Bielefeldt K, Binion DG. Opioid Analgesics Do Not Improve Abdominal Pain or Quality of Life in Crohn's Disease. Dig Dis Sci 2020;65:2379-87. [PMID: 31758431 DOI: 10.1007/s10620-019-05968-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
64 Sweeney L, Moss-morris R, Czuber-dochan W, Meade L, Chumbley G, Norton C. Systematic review: psychosocial factors associated with pain in inflammatory bowel disease. Aliment Pharmacol Ther 2018;47:715-29. [DOI: 10.1111/apt.14493] [Cited by in Crossref: 38] [Cited by in F6Publishing: 26] [Article Influence: 12.7] [Reference Citation Analysis]
65 Greenley RN, Kunz JH, Schurman JV, Swanson E. Abdominal pain and health related quality of life in pediatric inflammatory bowel disease. J Pediatr Psychol 2013;38:63-71. [PMID: 23027718 DOI: 10.1093/jpepsy/jss097] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]